Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Halozyme Therapeutics, Inc. (HALO) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$354.26M |
|
$175.22M |
|
$55.24M |
|
$299.02M |
|
$136.34M |
|
$217.92M |
|
$1.04M |
|
$218.96M |
|
$218.96M |
|
$175.22M |
|
$175.22M |
|
$175.22M |
|
$175.22M |
|
$217.92M |
|
$239.84M |
|
117.22M |
|
122.33M |
|
$1.49 |
|
$1.43 |
|
| Balance Sheet Financials | |
$1.33B |
|
$71.42M |
|
$892.48M |
|
$2.22B |
|
$837.23M |
|
$800.07M |
|
$880.09M |
|
$1.72B |
|
$503.92M |
|
$-261.45M |
|
$503.92M |
|
117.52M |
|
| Cash Flow Statement Financials | |
$432.53M |
|
$195.97M |
|
$-324.69M |
|
$115.85M |
|
$419.67M |
|
$303.81M |
|
$34.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.59 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
0.61 |
|
3.00 |
|
84.41% |
|
61.51% |
|
61.51% |
|
-- |
|
61.81% |
|
49.46% |
|
$875.86M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.30 |
|
1.02 |
|
87.91 |
|
34.77% |
|
-67.02% |
|
7.89% |
|
13.44% |
|
$4.29 |
|
$7.16 |
|
$3.54 |
|